Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
5-((6-Chlorohexyl)oxy)pentan-1-ol serves as a vital drug intermediate in the synthesis of diverse active pharmaceutical compounds. This reagent is instrumental in facilitating the construction of complex molecular architectures, contributing to the development of new therapeutic agents. Its versatile chemical properties make it a valuable tool in medicinal chemistry research and development. -
Drug Intermediate
1,3-Distearin, also known as 1,3-Distearoyl glycerol, serves as a crucial intermediate in the synthesis of non-steroidal anti-inflammatory agents. It is utilized in the production of drugs such as Ibuprofen, Naproxen, and Diclofenac, contributing to the development of therapeutic compounds for pain and inflammation management. This reagent is essential for research focused on drug synthesis and formulation in pharmacological studies. -
Drug Intermediate
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonyl fluoride serves as a versatile drug intermediate, facilitating the synthesis of diverse bioactive compounds. Its unique structural features enable efficient incorporation into complex chemical pathways, aiding in the development of pharmaceutical agents. This reagent is particularly valuable in medicinal chemistry and related research applications for the creation of sulfonamide derivatives and other functionalized molecules. -
Drug Intermediate
O-Acetyl-L-homoserine hydrochloride serves as a crucial intermediate in the biosynthesis of L-Methionine. It functions as an inhibitor of OAH sulfhydrylase (CaMet15p), impacting methionine metabolic pathways. This compound is primarily utilized in biochemical research focused on amino acid synthesis and enzyme inhibition studies. -
Drug Impurity
tert-Butyl (2-hydroxypropyl)carbamate is classified as a drug impurity. Its presence in pharmaceutical formulations can serve as a marker for the assessment of purity and stability in drug development. This compound is utilized in analytical chemistry to ensure the quality and safety of therapeutic agents. -
Drug Impurity
5''-Methyl-apixaban is a structural analogue of apixaban, primarily characterized as a drug impurity. This compound is relevant in analytical chemistry for the development and validation of quality control assays, ensuring the purity of apixaban formulations. Its assessment is vital for understanding the stability and safety profiles of pharmaceutical products containing apixaban. -
Drug Impurity
Aripiprazole impurity 1 is a specific chemical impurity associated with the antipsychotic agent Aripiprazole. Its identification and characterization are essential for quality control and regulatory compliance in pharmaceutical development. This impurity can be utilized in research focused on drug formulation stability, impurity profiling, and pharmacokinetic studies related to Aripiprazole. -
Drug Intermediate
2-Pyrimidineacetic acid serves as a versatile synthetic intermediate in pharmaceutical synthesis. This compound is utilized in the preparation of various bioactive molecules and can facilitate the development of therapeutic agents. Its role in drug discovery research highlights its importance in medicinal chemistry and related fields. -
Drug Intermediate
3-Methoxybenzothioamide is a chemical intermediate that exhibits notable reactivity in drug synthesis. This compound serves as a valuable building block in pharmaceutical research, facilitating the development of novel therapeutic agents. Its unique structural properties contribute to its utility in various chemical transformations necessary for creating diverse drug candidates. -
Drug Impurity
2-Bromo-1-(4-hydroxyphenyl)propan-1-one is identified as a drug impurity, characterized by its potential to influence the safety and efficacy profiles of pharmaceutical formulations. This compound may play a role in assessing the stability and consistency of drug products. Its relevance extends to applications in quality control, analytical chemistry, and pharmaceutical research to ensure compliance with regulatory standards. -
Drug Intermediate
tert-Butyl (4-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)butyl)carbamate serves as a critical drug intermediate in organic synthesis. This compound facilitates the formation of diverse bioactive molecules, playing an essential role in the development of pharmaceuticals targeting various biological pathways. Its unique structure allows for further functionalization, making it a valuable reagent in medicinal chemistry and drug discovery research. -
Drug Intermediate
DM-CO-(CH2)5-SH is a valuable drug intermediate utilized in the synthesis of antibody-drug conjugate (ADC) metabolites. This compound enables researchers to explore the pharmacokinetics and efficacy of ADCs in targeted cancer therapies. Its role as a synthetic building block makes it essential for advancing drug development and optimizing therapeutic strategies in chemical research. -
Drug Impurity
Edoxaban impurity 7 is a derived impurity of the anticoagulant Edoxaban, primarily identified for quality control purposes in pharmaceutical research. It is crucial for assessing the purity and stability of Edoxaban formulations during development and manufacturing processes. Analytical studies involving Edoxaban impurity 7 aid in the evaluation of drug safety and efficacy by ensuring compliance with regulatory standards in medicinal chemistry. -
Drug Intermediate
tert-Butyl (4-((5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)carbamate serves as a critical drug intermediate in the synthesis of diverse bioactive compounds. This compound's structure is integral for the development of pharmaceuticals targeting specific molecular pathways. Its applications in medicinal chemistry support the design and evaluation of potential therapeutic agents. -
Drug Intermediate
5,6-Dimethoxyindan-1-one is a versatile drug intermediate employed in the synthesis of diverse active pharmaceutical ingredients. It has applications in the development of antiviral compounds and acetylcholinesterase butyrylcholinesterase inhibitors. This reagent serves as a critical building block in medicinal chemistry, facilitating the exploration of new therapeutic agents. -
Drug Impurity
Pitavastatin impurity 1 is an impurity associated with the cholesterol-lowering agent Pitavastatin. This compound is relevant for assessing the purity and quality of pharmaceutical formulations containing Pitavastatin. It serves as an important tool in drug development and testing to ensure compliance with regulatory standards and to evaluate potential effects on efficacy and safety profiles. -
Drug Intermediate
7(Z),10(Z),13(Z)-Hexadecatrienoic acid, also known as Roughanic acid, functions as a drug intermediate in organic synthesis. This ω-3 polyunsaturated fatty acid (PUFA), extracted from the leaves of S. olusatrum, plays a crucial role in the biosynthesis of jasmonic acid. Its applications in chemical research chiefly involve the investigation of plant hormone pathways and the exploration of bioactive lipid compounds in various biological systems. -
Drug Impurity
Ibuprofen impurity 8 is a known impurity associated with the non-steroidal anti-inflammatory drug, Ibuprofen. This compound serves as a reference standard for analytical methods in pharmaceutical development and quality control. Its characterization and quantification are essential for ensuring the purity and efficacy of Ibuprofen formulations in compliance with regulatory standards. -
Drug Intermediate
Triacetylphloroglucinol is a symmetric three-dimensional bridged ligand that serves as a useful drug intermediate in organic synthesis. It facilitates the production of various compounds, including trinuclear vanadium Schiff base complexes, copper complexes, and anthelmintics. Its applications extend to the development of pharmacologically relevant materials and coordination chemistry. -
Drug Intermediate
3-(2-Chloroacetyl)-1H-indole-5-carbonitrile serves as an important drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. This compound is characterized by its unique indole structure, which contributes to its utility in medicinal chemistry research. Its versatility in organic synthesis makes it a valuable reagent for developing new therapeutic agents. -
Drug Impurity
Acebutolol impurity 5 is a known impurity associated with the pharmaceutical compound Acebutolol. This reagent can be utilized in the assessment of drug purity and stability, contributing to quality control and regulatory compliance in pharmaceutical development. Its role in analytical chemistry makes it essential for researchers focused on drug formulation and safety. -
Drug Impurity
Duloxetine impurity 11 is a chemical impurity associated with Duloxetine, a serotonin-norepinephrine reuptake inhibitor. This impurity can be relevant for assessing the quality and purity of pharmaceutical formulations containing Duloxetine. Research applications include analytical chemistry, pharmaceutical development, and stability testing to ensure compliance with regulatory standards. -
Drug Impurity
Apster Impurity 51 is a chemical impurity associated with pharmaceutical formulations. It serves as an important reference standard for analytical methods related to drug quality and safety. The compound is utilized in research applications focused on impurity profiling, stability testing, and compliance with regulatory guidelines for drug development. -
Drug Intermediate
(Z)-5-(4-Iodobenzylidene)-2-thioxothiazolidin-4-one serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound exhibits structural characteristics that facilitate various chemical reactions, making it valuable in medicinal chemistry research. Its applications extend to the development of novel therapeutic agents with potential biological activity. -
Drug Impurity
Sorafenib impurity 2 is a chemical impurity of the multikinase inhibitor Sorafenib. This impurity can be utilized for the qualitative analysis and characterization of Sorafenib formulations in pharmaceutical research. Its presence must be monitored to ensure the purity and efficacy of drug products in development and to assess their safety profiles in biological applications. -
Pyridoxine cyclic ether Impurity
6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol hydrochloride serves as a pyridoxine cyclic ether impurity. This compound is primarily utilized in chemical research focused on the characterization and analysis of pyridoxine derivatives. Its presence may impact the stability and efficacy of related compounds, making it an essential reference standard for quality control and purity assessments in pharmaceutical development. -
Drug Impurity
Sertraline impurity 14 is a chemical impurities derived from the selective serotonin reuptake inhibitor (SSRI) sertraline. This compound serves as a critical reference standard for the quality control and analysis of pharmaceutical formulations containing sertraline. Its characterization is essential for ensuring the purity and compliance of drug products, providing valuable insights into metabolite behavior and stability during research applications. -
Drug Impurity
Aripiprazole impurity 9 is identified as a pharmaceutical impurity of Aripiprazole. It serves as an important reference standard for quality control and analytical studies in drug development. This compound is essential for researchers focused on the identification and quantification of impurities in pharmaceutical formulations, ensuring compliance with regulatory standards. -
Drug Impurity
Apixaban impurity 4 is a known impurity of the anticoagulant Apixaban, primarily utilized for assessing drug purity and quality control during pharmaceutical development. Its presence can influence pharmacological efficacy and safety assessments, making it relevant in analytical chemistry and regulatory compliance studies. This reagent aids in the detailed characterization of Apixaban formulations and contributes to the understanding of potential variations in drug composition. -
Drug Impurity
Bupropion impurity 15, chemically identified as 3-Bromophenyl Ethyl Ketone, serves as a drug impurity associated with the antidepressant Bupropion. This compound is commonly used in the assessment of pharmaceutical quality and purity standards, as well as in the study of drug metabolism and pharmacokinetics. Its analysis is crucial for ensuring the safety and efficacy of Bupropion formulations in therapeutic applications. -
Drug Impurity
Ibrutinib impurity 2 is a chemical impurity associated with the drug Ibrutinib, which targets Bruton's tyrosine kinase (BTK). As a research reagent, it can be utilized in studies investigating the purity and stability of pharmaceutical formulations, as well as in the development of analytic methods for quality control. Its presence in formulations may influence drug efficacy and safety profiles, making it relevant for ongoing pharmaceutical research. -
Drug Impurity
Sitagliptin impurity 6 is a known impurity associated with the antidiabetic medication Sitagliptin. This compound may be utilized in quality control and validation processes for the characterization of Sitagliptin formulations. Its presence and analysis are important for ensuring the safety and efficacy of pharmaceutical products containing Sitagliptin. -
Drug Impurity
Aripiprazole impurity 27 is identified as a drug impurity associated with the antipsychotic agent Aripiprazole. This compound is important for analytical and quality control studies in pharmaceutical research, as it aids in assessing the purity and stability of Aripiprazole formulations. Its characterization is essential for regulatory compliance and ensuring the safety and efficacy of related therapeutic products. -
Biochemical Assay Reagent
4-Hydroxydiphenylamine, also known as p-Anilinophenol, functions as a biochemical assay reagent. Exhibiting antioxidant properties, it is utilized as a catalyst and intermediate in various chemical reactions for the synthesis of other compounds. This compound is valuable in research applications related to environmental science and toxicology, helping to analyze and understand chemical interactions and effects. -
Drug Impurity
Dacomitinib impurity 3 is a known impurity associated with the tyrosine kinase inhibitor Dacomitinib. This compound can be utilized in analytical studies to evaluate the purity and stability of pharmaceutical formulations containing Dacomitinib. Its characterization is essential for ensuring the quality and compliance of drug products in the development process. -
Drug Impurity
Clopidogrel impurity 3 is a known impurity associated with Clopidogrel, a popular antiplatelet medication. This compound serves as an important analytical reference in the assessment of drug purity and quality control. Its characterization is essential for the evaluation of formulation stability and potential pharmacological effects during research and development. -
Drug Impurity
Ticagrelor impurity 22 is a known impurity associated with Ticagrelor, a potent P2Y12 platelet receptor inhibitor. This compound is utilized in the characterization of drug formulations and is critical for ensuring the quality and safety of pharmaceutical products. Its study is essential for regulatory compliance and may assist in understanding the stability and degradation pathways of Ticagrelor-based therapies. -
Drug Intermediate
Cyanoacetohydrazide serves as a pharmaceutical intermediate, primarily utilized in the synthesis of acylhydrazide hydrazone derivatives. These derivatives have demonstrated notable antibacterial and anti-tumor activities, making cyanoacetohydrazide a valuable compound in drug development and medicinal chemistry research. Its versatile applications in synthesizing bioactive compounds contribute significantly to advancing therapeutic strategies. -
Drug Intermediate
3-(4-Chlorophenoxy)-4-methylaniline serves as a critical drug intermediate utilized in the synthesis of a range of active pharmaceutical ingredients. This compound is integral in the development of various therapeutic agents, enabling effective chemical transformations in medicinal chemistry. Its unique structural features allow for versatile applications in pharmaceutical research and development. -
Drug Impurity
Omeprazole impurity 13 is a chemical impurity associated with the proton pump inhibitor omeprazole. It is utilized primarily in drug quality control and stability studies to ensure the purity of omeprazole formulations. The characterization of this impurity is crucial for regulatory compliance and assessing the safety and efficacy of pharmaceutical products containing omeprazole. -
Biochemical Reagent
Drotaveraldine is a biochemical reagent that participates in domino reactions with α,β-unsaturated aldehydes. Through these reactions, it enables the synthesis of pyrrolo[2,1-a]isoquinolines, which are valuable intermediates in chemical research. This compound is utilized in studies focused on organic synthesis and the development of novel biochemical pathways. -
Drug Impurity
2-Hydroxy-3-nitrobenzaldehyde is characterized as a drug impurity, primarily affecting the purity profile of pharmaceutical compounds. This compound serves as an important reference standard in analytical chemistry, utilized in the assessment of drug formulations and in quality control processes. Its presence can impact pharmacokinetics and safety evaluations, making it relevant for research focusing on drug development and regulatory compliance. -
Drug Impurity
Vitamin Impurity 2 is a known impurity associated with Vitamin compounds. It serves as a critical reference standard in pharmaceutical research and development to evaluate the purity and quality of Vitamin formulations. Its identification and quantification are essential for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Intermediate
2,3,4-Tri-O-acetyl-β-D-glucuronide methyl ester is a synthetic intermediate utilized in the preparation of prodrug forms of the antitumor antibiotic Daunomycin. This compound exhibits crucial functionalities in glycosylation reactions, facilitating drug development and optimization. Its applications in medicinal chemistry and pharmaceutical research make it a valuable reagent for advancing therapeutic formulations in oncology research. -
Drug Intermediate
42-O-(2-Azidoethyl)-Rapamycin is an azide-modified derivative of Rapamycin, functioning as an important drug intermediate for synthetic applications. It facilitates the development of Rapamycin derivatives, which are of interest in various therapeutic contexts, particularly in cancer research and immunosuppression studies. This compound's unique structure allows for further modifications that can enhance biological activity and specificity in target engagement. -
Drug Intermediate
Methyl (3S,6R)-6-methyl-3-piperidinecarboxylate L-tartaric acid salt serves as a versatile drug intermediate in the synthesis of various bioactive compounds. This compound plays a crucial role in the preparation of pharmaceutical agents, contributing to diverse chemical structures and medicinal properties. Its application is significant in the fields of medicinal chemistry and drug development. -
Drug Impurity
Sunitinib impurity 28 is a recognized impurity associated with Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor. It serves as a critical reference standard in the analysis of Sunitinib and is pivotal for assessing drug purity and stability in pharmaceutical formulations. This impurity is essential for quality control and research applications focused on the metabolism and pharmacokinetics of Sunitinib. -
Drug Impurity
Afatinib impurity 34 is a known impurity associated with the drug Afatinib, an irreversible ErbB receptor tyrosine kinase inhibitor. This compound is primarily utilized for quality control and analytical studies in pharmaceutical development to ensure the purity and compliance of Afatinib formulations. Its characterization is essential for understanding the potential impact of impurities on drug efficacy and safety profiles. -
Drug Intermediate
6,7-Dibromoquinoline-5,8-dione is a versatile drug intermediate utilized in the synthesis of a variety of biologically active compounds. This compound serves as a crucial building block in medicinal chemistry and pharmaceutical development, facilitating the creation of novel therapeutic agents. Its incorporation into chemical reactions can lead to the development of compounds with potential applications in diverse areas of drug discovery and development. -
Drug Impurity
Methyl 3-chlorobenzoate is a compound commonly categorized as a drug impurity. It is utilized in chemical research to study the implications of impurities in drug development processes. This reagent serves as a valuable tool for evaluating the stability and efficacy of pharmaceutical formulations.
